Jul. 6 at 3:17 PM
$INMB INCOMING CATALYST ( AI BASED DD)
The Mid-July Catalyst: AAIC 2026 (July 12–15)
The entire probability of hitting
$2.00 by July 20th hinges on the Alzheimer’s Association International Conference (AAIC).
The Setup: On June 2nd, INMB shares popped when they announced headline Phase 2 MINDFuL data showing a statistically significant treatment effect on an advanced white matter MRI biomarker (
$P=0.0028$).
The Event: At AAIC, the company will present the complete dataset and full analysis.
The Impact: Biotech stocks frequently see aggressive accumulation leading up to a major presentation, followed by high-velocity volatility once the full presentation slides hit the public. If the granular data confirms robust target engagement and clinical correlation without unexpected adverse safety signals, a 17.6% move from
$1.70 to
$2.00+ is well within the typical historical standard deviation for this ticker.
